genetic hypoparathyroidism
ORPHA: 2085931 Treatment Available
Overview
Genetic hypoparathyroidism
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| calcitriol | oral capsule 0.25mcg, 0.5mcg; oral solution 1mcg/mL; IV injection 1mcg/mL | FDA Approved | 9 | 5d |
Classification & Codes
Orphanet Code
ORPHA:208593genetic hypoparathyroidism
| Orphanet | ORPHA:208593 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO